TapewireFind a company

person · Reporting owner

O'Rourke Timothy Patrick

Disclosed activity across 1 company

Tapewire entity
48241
SEC CIK
0002134052

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
agilon health, inc.AGL · Entity 4698Director · CEO & PresidentMay 07, 2026May 11, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

agilon health, inc.

Report date May 07, 2026 · Filed May 11, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect320,000 Last balance in matching sequence After 2026-05-07 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2026-05-07 · Grant · Acquired 120,000 · Balance 120,000

F1: Restricted stock units that vest in three equal installments on each anniversary of May 7, 2026, subject to continued employment.

F2: Includes restricted stock units.

Row 2 · 2026-05-07 · Grant · Acquired 200,000 · Balance 320,000

F3: Performance stock units may become vested subject to attainment during the three-year performance period (one-third vests if 30-trading-day weighted average price is equal or greater than $50, one-third vests if 30-trading-day weighted average price is equal or greater than $100, one-third vest if 30-trading-day weighted average price is equal or greater than $150) and continued employment through the end of such three-year performance period.

F2: Includes restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units that vest in three equal installments on each anniversary of May 7, 2026, subject to continued employment.

F2: Includes restricted stock units.

F3: Performance stock units may become vested subject to attainment during the three-year performance period (one-third vests if 30-trading-day weighted average price is equal or greater than $50, one-third vests if 30-trading-day weighted average price is equal or greater than $100, one-third vest if 30-trading-day weighted average price is equal or greater than $150) and continued employment through the end of such three-year performance period.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 07, 2026 Filed May 11, 2026 21:05 UTC agilon health, inc. AGL · Entity 4698 GrantCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-033651 · wk-form4_1778533553.xml · nonDerivative · entry 2

O'Rourke Timothy Patrick · CIK 0002134052 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 320,000

F3 · shares: Performance stock units may become vested subject to attainment during the three-year performance period (one-third vests if 30-trading-day weighted average price is equal or greater than $50, one-third vests if 30-trading-day weighted average price is equal or greater than $100, one-third vest if 30-trading-day weighted average price is equal or greater than $150) and continued employment through the end of such three-year performance period.

F2 · balance_after: Includes restricted stock units.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:05 UTC agilon health, inc. AGL · Entity 4698 GrantCommon Stock 120,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-033651 · wk-form4_1778533553.xml · nonDerivative · entry 1

O'Rourke Timothy Patrick · CIK 0002134052 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

F1 · shares: Restricted stock units that vest in three equal installments on each anniversary of May 7, 2026, subject to continued employment.

F2 · balance_after: Includes restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.